SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-027432
Filing Date
2017-02-01
Accepted
2017-02-01 16:02:06
Documents
14

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424(B)(5) d326600d424b5.htm 424B5 556494
2 GRAPHIC g326600g09k06.jpg GRAPHIC 77419
3 GRAPHIC g326600g27e76.jpg GRAPHIC 73717
4 GRAPHIC g326600g31a53.jpg GRAPHIC 40192
5 GRAPHIC g326600g42h18.jpg GRAPHIC 111000
6 GRAPHIC g326600g55m39.jpg GRAPHIC 33345
7 GRAPHIC g326600g60b51.jpg GRAPHIC 67167
8 GRAPHIC g326600g64l82.jpg GRAPHIC 98154
9 GRAPHIC g326600g73a92.jpg GRAPHIC 25606
10 GRAPHIC g326600g74m10.jpg GRAPHIC 62808
11 GRAPHIC g326600g75k85.jpg GRAPHIC 64682
12 GRAPHIC g326600g79n38.jpg GRAPHIC 54651
13 GRAPHIC g326600g89g88.jpg GRAPHIC 30205
14 GRAPHIC g326600g98h56.jpg GRAPHIC 39490
  Complete submission text file 0001193125-17-027432.txt   1631631
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-200006 | Film No.: 17564920
SIC: 2834 Pharmaceutical Preparations